Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Saratoga Investment Corp. | SAR | 20.76K | $463.09K |
BioMarin Pharmaceutical Inc. | BMRN | 20.78K | $1.19M |
Jade Biosciences, Inc. | JBIO | 21.33K | $473.93K |
Robinhood Markets, Inc. | HOOD | 21.47K | $2.15M |
Edwards Lifesciences Corporation | EW | 21.59K | $1.95M |
Exelixis, Inc. | EXEL | 21.89K | $1.19M |
Relay Therapeutics, Inc. | RLAY | 22.09K | $413.38K |
Carvana Co. | CVNA | 22.15K | $1.46M |
Gladstone Investment Corp. | GAIN | 22.22K | $343.57K |
Sixth Street Specialty Lending, Inc. | TSLX | 22.23K | $381.69K |
Travere Therapeutics, Inc. | TVTX | 22.35K | $1.27M |
Kiniksa Pharmaceuticals International, plc | KNSA | 22.41K | $1.43M |
Amylyx Pharmaceuticals, Inc. | AMLX | 22.43K | $402.77K |
MetLife, Inc. | MET | 23.2K | $1.96M |
Erasca, Inc. | ERAS | 23.29K | $426.64K |
Moderna, Inc. | MRNA | 23.3K | $1.63M |
SunCoke Energy, Inc. | SXC | 23.33K | $187.79K |
CRISPR Therapeutics AG | CRSP | 23.35K | $1.27M |
Summit Therapeutics Inc. | SMMT | 23.36K | $340.28K |
Gilead Sciences, Inc. | GILD | 23.37K | $2.95M |